Member Exclusive

Study implicates the role of epigenetic enzyme in Crohn's disease

Researchers at Massachusetts General Hospital (Boston, MA, USA) have highlighted how a variant in an epigenetic enzyme interferes with the action of the innate immune system and intestinal health. These findings provide possible treatment routes for inflammatory bowel diseases.

Go to the profile of Joe Martin
Mar 10, 2017
0
0

Please sign in or register for FREE to view this content

Register to EpigenomicsNet – the epigenetics and epigenomics network

EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet. Start the conversation...